The autotransfusion devices market in Asia-Pacific is expected to grow from US$ 250.35 million in 2021 to US$ 349.09 million by 2028; it is estimated to grow at a CAGR of 4.9% from 2021 to 2028.
Healthcare budget allocations help countries in strengthening the workforces and improving the productivity of this sector, thereby contributing to economic performance. Rapid economic developments in India, China and other countries in Asia have augmented the healthcare expenditure in these countries, which enables them to establish better medical service infrastructure. Developing countries are significantly focusing on expanding and improving their healthcare facilities and services by leveraging technological advancements. The developing nations are focusing on introducing advanced healthcare facilities and services to overcome critical health issues. For instance, the government of India, through its National Health Authority agency, has implemented Ayushman Bharat – Pradhan Mantri Jan Arogya Yojana (AB-PMJAY). This scheme has facilitated free/affordable treatment for cancer patients in the country. As per the data published by the National Health Authority of India, about 470,133 cancer cases have been treated under AB-PMJAY. These government initiatives are likely to provide lucrative opportunities for market players to introduce advanced technologies in autotransfusion devices, which, in turn, would propel the growth of the autotransfusion devices market during the forecast years.
Asia-Pacific Autotransfusion Devices Market Revenue and Forecast to 2028 (US$ Million)
- This FREE sample will include data analysis, ranging from market trends to estimates and forecasts.
Asia-Pacific Autotransfusion Devices Market Segmentation
The Asia-Pacific autotransfusion devices market is segmented on the basis of type, application, end user, and country. The market, by type, is bifurcated into products and accessories. In 2021, the accessories segment held a larger market share. The market for the products segment is further segmented into intraoperative autotransfusion systems, postoperative autotransfusion systems, and dual-mode autotransfusion systems. In 2021, the intraoperative autotransfusion systems segment held the largest market share. The Asia-Pacific autotransfusion devices market, by application, is segmented into cardiac surgeries, orthopedic surgeries, organ transplantation, trauma procedures, and others. The cardiac surgeries segment held the largest market share in 2021. Based on end user, the market is segmented into hospitals, specialty clinics, and ambulatory surgical centers. The hospitals segment held the largest share of the market in 2021. Based on country, the market is segmented into China, Japan, India, South Korea, Australia, and the rest of Asia-Pacific. Japan contributed a substantial share in 2021.
BD, Braile Biomedica, Fresenius SE & Co. KGaA, Haemonetics Corporation, LivaNova PLC, Medtronic, Redax S.p.A., SARSTEDT AG and Co. KG, Teleflex Incorporated, and Zimmer Biomet are among the leading companies in the Asia-Pacific autotransfusion devices market.
Asia Pacific Autotransfusion Devices Report Scope
Report Attribute | Details |
---|---|
Market size in 2021 | US$ 250.35 Million |
Market Size by 2028 | US$ 349.09 Million |
Global CAGR (2021 - 2028) | 4.9% |
Historical Data | 2019-2020 |
Forecast period | 2022-2028 |
Segments Covered |
By Type
|
Regions and Countries Covered | Asia-Pacific
|
Market leaders and key company profiles |
- Historical Analysis (2 Years), Base Year, Forecast (7 Years) with CAGR
- PEST and SWOT Analysis
- Market Size Value / Volume - Global, Regional, Country
- Industry and Competitive Landscape
- Excel Dataset
Testimonials

I wish to appreciate your support and the professionalism you displayed in the course of attending to my request for information regarding to infectious disease IVD market in Nigeria. I appreciate your patience, your guidance, and the fact that you were willing to offer a discount, which eventually made it possible for us to close a deal. I look forward to engaging The Insight Partners in the future, all thanks to the impression you have created in me as a result of this first encounter.
DR CHIJIOKE ONYIA, MANAGING DIRECTOR, PineCrest Healthcare Ltd.
The Insight Partners delivered insightful, well-structured market research with strong domain expertise. Their team was professional and responsive throughout. The user-friendly website made accessing industry reports seamless. We highly recommend them for reliable, high-quality research services
Yukihiko Adachi CEO, Deep Blue, LLC.Reason to Buy
- Informed Decision-Making
- Understanding Market Dynamics
- Competitive Analysis
- Customer Insights
- Market Forecasts
- Risk Mitigation
- Strategic Planning
- Investment Justification
- Identifying Emerging Markets
- Enhancing Marketing Strategies
- Boosting Operational Efficiency
- Tracking Industry Innovations
- Aligning with Regulatory Trends
Yes! We provide a free sample of the report, which includes Report Scope (Table of Contents), report structure, and selected insights to help you assess the value of the full report. Please click on the "Download Sample" button or contact us to receive your copy.
Absolutely — analyst assistance is part of the package. You can connect with our analyst post-purchase to clarify report insights, methodology or discuss how the findings apply to your business needs.
Once your order is successfully placed, you will receive a confirmation email along with your invoice.
• For published reports: You’ll receive access to the report within 4–6 working hours via a secured email sent to your email.
• For upcoming reports: Your order will be recorded as a pre-booking. Our team will share the estimated release date and keep you informed of any updates. As soon as the report is published, it will be delivered to your registered email.
We offer customization options to align the report with your specific objectives. Whether you need deeper insights into a particular region, industry segment, competitor analysis, or data cut, our research team can tailor the report accordingly. Please share your requirements with us, and we’ll be happy to provide a customized proposal or scope.
The report is available in either PDF format or as an Excel dataset, depending on the license you choose.
The PDF version provides the full analysis and visuals in a ready-to-read format. The Excel dataset includes all underlying data tables for easy manipulation and further analysis.
Please review the license options at checkout or contact us to confirm which formats are included with your purchase.
Our payment process is fully secure and PCI-DSS compliant.
We use trusted and encrypted payment gateways to ensure that all transactions are protected with industry-standard SSL encryption. Your payment details are never stored on our servers and are handled securely by certified third-party processors.
You can make your purchase with confidence, knowing your personal and financial information is safe with us.
Yes, we do offer special pricing for bulk purchases.
If you're interested in purchasing multiple reports, we’re happy to provide a customized bundle offer or volume-based discount tailored to your needs. Please contact our sales team with the list of reports you’re considering, and we’ll share a personalized quote.
Yes, absolutely.
Our team is available to help you make an informed decision. Whether you have questions about the report’s scope, methodology, customization options, or which license suits you best, we’re here to assist. Please reach out to us at sales@theinsightpartners.com, and one of our representatives will get in touch promptly.
Yes, a billing invoice will be automatically generated and sent to your registered email upon successful completion of your purchase.
If you need the invoice in a specific format or require additional details (such as company name, GST, or VAT information), feel free to contact us, and we’ll be happy to assist.
Yes, certainly.
If you encounter any difficulties accessing or receiving your report, our support team is ready to assist you. Simply reach out to us via email or live chat with your order information, and we’ll ensure the issue is resolved quickly so you can access your report without interruption.















- BD
- Braile Biomedica
- Fresenius SE & Co. KGaA
- Haemonetics Corporation
- LivaNova PLC
- Medtronic
- Redax S.p.A.
- SARSTEDT AG and Co. KG
- Teleflex Incorporated
- Zimmer Biomet


